Targeted Therapies in Cancer Myth or Reality? /

No BCC for this title.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Colotta, Francesco (Επιμελητής έκδοσης), Mantovani, Alberto (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York, 2008.
Σειρά:Advances in Experimental Medicine and Biology, 610
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02851nam a22005295i 4500
001 978-0-387-73898-7
003 DE-He213
005 20151120201649.0
007 cr nn 008mamaa
008 100301s2008 xxu| s |||| 0|eng d
020 |a 9780387738987  |9 978-0-387-73898-7 
024 7 |a 10.1007/978-0-387-73898-7  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Targeted Therapies in Cancer  |h [electronic resource] :  |b Myth or Reality? /  |c edited by Francesco Colotta, Alberto Mantovani. 
264 1 |a New York, NY :  |b Springer New York,  |c 2008. 
300 |a VIII, 191 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 610 
505 0 |a Causality in Medicine -- The Evolution of the Biomedical Paradigm in Oncology: Implications for Cancer Therapy -- Anticancer Drug Discovery and Development -- Beyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms -- Aurora Kinases and Their Inhibitors: More Than One Target and One Drug -- Signalling Pathways and Adhesion Molecules as Targets for Antiangiogenesis Therapy in Tumors -- Developing T-Cell Therapies for Cancer in an Academic Setting -- Anticancer Cell Therapy with TRAIL-Armed CD34+ Progenitor Cells -- Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies -- Clinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned? -- GIST As the Model of Paradigm Shift Towards Targeted Therapy of Solid Tumors: Update and Perspective on Trial Design -- Monoclonal Antibodies in the Treatment of Malignant Lymphomas -- Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy. 
520 |a No BCC for this title. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Human genetics. 
650 0 |a Human physiology. 
650 0 |a Developmental biology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Cancer Research. 
650 2 4 |a Human Genetics. 
650 2 4 |a Medicine/Public Health, general. 
650 2 4 |a Human Physiology. 
650 2 4 |a Developmental Biology. 
700 1 |a Colotta, Francesco.  |e editor. 
700 1 |a Mantovani, Alberto.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9780387738970 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 610 
856 4 0 |u http://dx.doi.org/10.1007/978-0-387-73898-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)